New Delhi: Drug firm Lupin Ltd today said it has received American health regulator`s approval to market Escitalopram tablets, used in treating depressive disorders, in the US market. The company`s subsidiary Lupin Pharmaceuticals Inc has received final approval from US Food and Drug Administration (USFDA) for its Escitalopram tablets in strengths of 5 mg, 10 mg, and 20 mg, Lupin said in a statement.
Aamir Khan dares Salman Khan to drop his pants
High-tech car theft: Thieves clone key codes to steal cars
Students develop charger that charges as you walk!
Maharashtra CM Prithviraj Chavan not to share dais with Narendra Modi